This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Adamed Pharma S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sabina Jelen: Innovator in Therapeutic Agents
Introduction
Sabina Jelen is a notable inventor based in Warsaw, Poland. She has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that activate TP53, a crucial protein in cancer prevention and treatment.
Latest Patents
Sabina Jelen holds 1 patent for her invention titled "1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-C]pyrrole]-2,3'-dione compounds as therapeutic agents activating TP53." This invention relates to compounds represented by a specific formula, which can be utilized in the prevention and treatment of various diseases, including cancer, immune diseases, inflammatory conditions, and viral infections.
Career Highlights
Sabina Jelen is currently employed at Adamed Pharma S.A., where she continues to innovate and contribute to the pharmaceutical industry. Her work focuses on developing new therapeutic solutions that can improve patient outcomes.
Collaborations
Throughout her career, Sabina has collaborated with talented individuals such as Marcin Feder and Maria Mazur, enhancing her research and development efforts.
Conclusion
Sabina Jelen's work in the field of therapeutic agents showcases her dedication to advancing medical science. Her innovative compounds hold promise for treating serious health conditions, making her a valuable contributor to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile